Treatment: Prescription Acne Treatment

txt (Miami Herald) - 187 weeks ago

Searching the Web for health information can be like negotiating a minefield of vested interests. Acne.com is proudly brought to you by a blemish remover. Prostate.com is run by a pharmaceutical company pushing a drug. Diabetes.com is operated by GlaxoSmithKline, which makes Avandia, one of the top drugs for guess-what.

Txt: CONSUMERS ARE INCREASINGLY FINDING ANSWERS ON DRUGS AND HEALTH ON THE WEB (RedNova) - 187 weeks ago

By John Dorschner, The Miami Herald Dec. 24--Searching the Web for health information can be like negotiating a minefield of vested interests. Acne.com is proudly brought to you by a blemish remover. Prostate.com is run by a pharmaceutical company pushing a drug.

QLT Inc. sells U.S. generic dermatology and manufacturing business for US$21M (CP via Yahoo! Canada News) - 187 weeks ago

VANCOUVER (CP) - QLT Inc. (TSX:QLT) has sold its generic dermatology and manufacturing business in Fort Collins, Colo. to privately held Tolmar Inc. for US$21 million as the Vancouver company continues to refocus its business on eye treatment drugs.

IN BRIEF (The Providence Journal) - 187 weeks ago

Which one is the nurse?

CollaGenex, MediGene ink European rosacea treatment deal (BizJournals) - 188 weeks ago

CollaGenex Pharmaceuticals Inc. signed a license and supply agreement Wednesday with MediGene AG for marketing rights to Oracea, CollaGenex's flagship dermatology product, in the European Union, other contiguous countries and Russia.

CollaGenex Pharmaceuticals Signs License and Supply Agreement with MediGene for Marketing Rights to Oracea in EU and ... (FinanzNachrichten) - 188 weeks ago

CollaGenex Pharmaceuticals, ( Nachrichten ) Inc. (NASDAQ:CGPI) today announced that it has signed a License and Supply Agreement with MediGene AG ( Nachrichten / Aktienkurs ) for marketing rights to Oracea(TM), CollaGenex ' s flagship dermatology product for the systemic treatment of rosacea, in the European Union, certain contiguous countries and Russia.

'Plymouth Pharmaceuticals(R) and Dermatologist Launch New Oral Prescription Acne Medication (Acunol(TM))' (RedNova) - 189 weeks ago

TULSA, Okla., Dec. 11 /PRNewswire/ -- Plymouth Pharmaceuticals(R), Inc. announced today that it has launched a new oral prescription medication for the treatment of acne and rosacea. Dermatologist, Dr. Steven A. Smith, MD, FACP, based in Tulsa, Okla.